Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Shmuel Yaccoby

Concepts (361)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
72
2023
2998
5.400
 Why?
Osteoclasts
18
2015
427
2.710
 Why?
Bone Diseases
7
2014
96
2.270
 Why?
Gene Expression Regulation, Neoplastic
14
2018
833
1.730
 Why?
Osteoblasts
13
2012
462
1.460
 Why?
Neoplasm Proteins
7
2018
320
1.300
 Why?
Mice, SCID
23
2015
178
1.270
 Why?
Osteolysis
6
2013
74
1.240
 Why?
Boronic Acids
13
2013
183
1.220
 Why?
Coculture Techniques
12
2015
142
1.180
 Why?
Bone Marrow
10
2018
363
1.080
 Why?
Bone Marrow Cells
6
2015
196
1.010
 Why?
Bone Neoplasms
3
2014
179
0.990
 Why?
Cell Differentiation
14
2018
640
0.960
 Why?
Bone and Bones
9
2014
478
0.940
 Why?
Pyrazines
12
2013
188
0.920
 Why?
Mice
32
2015
5687
0.910
 Why?
Proteoglycans
6
2008
83
0.880
 Why?
Protein-Tyrosine Kinases
2
2014
88
0.850
 Why?
Cell Proliferation
11
2023
985
0.800
 Why?
Neoplastic Stem Cells
2
2017
98
0.750
 Why?
Cell Communication
3
2015
68
0.750
 Why?
Animals
35
2016
13124
0.710
 Why?
Intercellular Signaling Peptides and Proteins
4
2010
102
0.700
 Why?
Osteogenesis
5
2012
356
0.690
 Why?
Membrane Glycoproteins
8
2009
245
0.670
 Why?
Bone Resorption
4
2011
302
0.670
 Why?
Cell Movement
6
2014
247
0.660
 Why?
Adipocytes
2
2018
126
0.640
 Why?
Humans
72
2023
50516
0.630
 Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.620
 Why?
Antineoplastic Agents
10
2015
1172
0.610
 Why?
Gene Expression
3
2018
610
0.580
 Why?
Gene Expression Profiling
9
2023
1025
0.550
 Why?
Gene Expression Regulation, Enzymologic
2
2017
179
0.550
 Why?
Thalidomide
8
2016
378
0.520
 Why?
Cell Survival
9
2015
589
0.520
 Why?
Protease Inhibitors
4
2010
58
0.520
 Why?
Tumor Microenvironment
2
2015
222
0.510
 Why?
Plasma Cells
8
2012
221
0.510
 Why?
Disease Models, Animal
8
2016
1436
0.490
 Why?
Cytokines
3
2015
606
0.490
 Why?
Cysteine-Rich Protein 61
1
2014
3
0.470
 Why?
Nicotinamide Phosphoribosyltransferase
1
2013
6
0.420
 Why?
Angiogenesis Inhibitors
3
2010
183
0.410
 Why?
Cell Line, Tumor
10
2015
1398
0.410
 Why?
Mesenchymal Stem Cell Transplantation
1
2012
19
0.400
 Why?
Rabbits
6
2013
372
0.400
 Why?
Parathyroid Hormone
4
2010
149
0.380
 Why?
Up-Regulation
3
2013
446
0.380
 Why?
Wnt Proteins
2
2010
98
0.370
 Why?
Signal Transduction
6
2013
1624
0.340
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2016
1000
0.330
 Why?
Transplantation, Heterologous
7
2009
75
0.330
 Why?
Receptor, EphB4
1
2009
5
0.330
 Why?
Ephrin-B2
1
2009
5
0.330
 Why?
Placenta
1
2011
134
0.330
 Why?
Fenretinide
1
2009
5
0.330
 Why?
Models, Biological
4
2010
716
0.320
 Why?
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
1
2009
6
0.320
 Why?
Dipeptides
1
2009
22
0.320
 Why?
Disease Progression
8
2014
829
0.320
 Why?
Cell Adhesion Molecules
1
2009
86
0.310
 Why?
Bone Development
1
2009
65
0.300
 Why?
Tumor Necrosis Factor Ligand Superfamily Member 13
1
2007
3
0.290
 Why?
Transmembrane Activator and CAML Interactor Protein
1
2007
6
0.290
 Why?
Extracellular Matrix Proteins
1
2008
68
0.290
 Why?
Apoptosis
8
2012
1097
0.290
 Why?
Bone Remodeling
4
2012
149
0.280
 Why?
Prognosis
12
2018
1977
0.280
 Why?
Recombinant Fusion Proteins
1
2007
179
0.270
 Why?
Melphalan
3
2016
178
0.270
 Why?
Tumor Cells, Cultured
8
2013
457
0.260
 Why?
Immunohistochemistry
5
2015
957
0.260
 Why?
Neoplasm Recurrence, Local
3
2023
629
0.260
 Why?
Antibodies
1
2006
153
0.260
 Why?
Cell Division
6
2004
291
0.250
 Why?
Serine Endopeptidases
1
2006
51
0.250
 Why?
RNA, Small Interfering
4
2013
208
0.250
 Why?
Antigens, Neoplasm
1
2006
148
0.240
 Why?
Severe Combined Immunodeficiency
1
2005
12
0.240
 Why?
Neovascularization, Pathologic
4
2009
155
0.240
 Why?
Alkaline Phosphatase
6
2017
93
0.230
 Why?
Syndecan-1
6
2007
75
0.230
 Why?
NF-kappa B
4
2013
315
0.230
 Why?
Hematopoietic Stem Cells
3
2012
197
0.220
 Why?
Receptors, CXCR4
2
2014
30
0.220
 Why?
Flow Cytometry
6
2015
474
0.220
 Why?
Gene Knockdown Techniques
2
2014
105
0.220
 Why?
Bone Density
3
2010
387
0.210
 Why?
Positron-Emission Tomography
2
2017
293
0.210
 Why?
Translocation, Genetic
2
2021
240
0.210
 Why?
Killer Cells, Natural
2
2015
106
0.210
 Why?
Stromal Cells
1
2003
75
0.200
 Why?
Transcription Factors
2
2023
565
0.200
 Why?
Female
21
2018
27086
0.200
 Why?
Neoplasm Transplantation
3
2014
86
0.200
 Why?
Immunophenotyping
2
2015
105
0.190
 Why?
Immunotherapy, Adoptive
2
2015
163
0.190
 Why?
Cell Line
2
2015
988
0.190
 Why?
T-Lymphocytes
2
2015
325
0.190
 Why?
Immunoglobulin Light Chains
2
2015
84
0.190
 Why?
Epigenomics
1
2021
68
0.190
 Why?
Antibodies, Monoclonal
4
2016
462
0.180
 Why?
Bone Transplantation
4
2010
45
0.180
 Why?
Decorin
2
2012
7
0.180
 Why?
Oligonucleotide Array Sequence Analysis
4
2015
405
0.170
 Why?
Cells, Cultured
4
2013
1571
0.170
 Why?
Drug Resistance, Neoplasm
2
2015
316
0.160
 Why?
Neoplasm Metastasis
2
2014
232
0.160
 Why?
Syndecans
5
2006
37
0.160
 Why?
Genes, myc
1
2019
32
0.160
 Why?
Cell Adhesion
2
2014
157
0.160
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2015
572
0.150
 Why?
Male
17
2018
25913
0.150
 Why?
Mice, Transgenic
4
2007
540
0.150
 Why?
Risk Factors
5
2018
3723
0.150
 Why?
Cyclin-Dependent Kinases
2
2015
26
0.150
 Why?
Monoclonal Gammopathy of Undetermined Significance
2
2018
112
0.140
 Why?
Diffusion Magnetic Resonance Imaging
1
2018
125
0.140
 Why?
Hexokinase
1
2017
17
0.140
 Why?
Chromosome Aberrations
3
2016
280
0.140
 Why?
Chromosomes, Human, Pair 17
1
2017
34
0.140
 Why?
Tumor Suppressor Protein p53
2
2017
213
0.140
 Why?
Disease-Free Survival
5
2018
444
0.140
 Why?
Calcification, Physiologic
1
2017
40
0.140
 Why?
Proteasome Inhibitors
2
2016
104
0.140
 Why?
Pelvis
1
2017
66
0.140
 Why?
Stem Cells
2
2009
166
0.130
 Why?
Chromosome Deletion
1
2017
134
0.130
 Why?
Biopsy
2
2018
588
0.130
 Why?
Neoplasm, Residual
1
2017
160
0.130
 Why?
Neoplasms, Experimental
2
2007
110
0.130
 Why?
Recurrence
3
2014
659
0.130
 Why?
Pyridinium Compounds
1
2015
21
0.130
 Why?
Base Sequence
2
2008
639
0.130
 Why?
Fluorodeoxyglucose F18
1
2017
189
0.130
 Why?
Endothelial Cells
2
2009
258
0.130
 Why?
Homologous Recombination
1
2015
41
0.120
 Why?
Benzimidazoles
1
2015
48
0.120
 Why?
Xenograft Model Antitumor Assays
3
2015
212
0.120
 Why?
Peptide Nucleic Acids
1
2015
18
0.120
 Why?
Rad51 Recombinase
1
2015
23
0.120
 Why?
Genes, Neoplasm
1
2015
27
0.120
 Why?
Aged
11
2017
9743
0.120
 Why?
Bromodeoxyuridine
2
2005
18
0.120
 Why?
Immunologic Factors
1
2016
111
0.120
 Why?
Time Factors
7
2017
2935
0.120
 Why?
Genomic Instability
1
2015
90
0.120
 Why?
Diphosphonates
2
2008
90
0.120
 Why?
Carrier Proteins
4
2008
298
0.120
 Why?
Antigens, CD
1
2015
222
0.110
 Why?
Asymptomatic Diseases
1
2014
37
0.110
 Why?
Immunotherapy
1
2016
235
0.110
 Why?
Proteome
1
2015
169
0.110
 Why?
Interleukin-6
2
2005
261
0.110
 Why?
Nicotinamide Mononucleotide
1
2013
4
0.110
 Why?
Acrylamides
1
2013
7
0.110
 Why?
Antigens, CD19
2
2005
29
0.100
 Why?
Poly(ADP-ribose) Polymerases
1
2013
29
0.100
 Why?
Niacinamide
1
2013
23
0.100
 Why?
Amides
1
2013
35
0.100
 Why?
NAD
1
2013
41
0.100
 Why?
Enzyme Induction
1
2013
79
0.100
 Why?
Nitriles
1
2013
52
0.100
 Why?
Sirtuin 1
1
2013
28
0.100
 Why?
Enzyme Inhibitors
2
2013
377
0.100
 Why?
Chemokine CXCL12
1
2013
33
0.100
 Why?
beta Catenin
1
2013
97
0.100
 Why?
Proteomics
1
2015
314
0.100
 Why?
Tumor Burden
2
2010
130
0.100
 Why?
Middle Aged
11
2018
12613
0.100
 Why?
Oligopeptides
1
2013
95
0.100
 Why?
Leukemia
1
2013
65
0.100
 Why?
Myelodysplastic Syndromes
1
2013
78
0.100
 Why?
Magnetic Resonance Imaging
2
2012
1556
0.100
 Why?
Injections, Intravenous
1
2012
137
0.100
 Why?
Proto-Oncogene Proteins c-jun
2
2009
77
0.100
 Why?
Piperidines
1
2013
99
0.100
 Why?
Cytotoxicity, Immunologic
1
2012
55
0.100
 Why?
Myeloma Proteins
2
2004
26
0.100
 Why?
Remission Induction
1
2012
208
0.100
 Why?
RNA, Messenger
3
2015
1089
0.100
 Why?
Neoplasm Staging
3
2015
746
0.090
 Why?
Anti-Inflammatory Agents
1
2012
163
0.090
 Why?
Renal Insufficiency
1
2012
110
0.090
 Why?
Glycoproteins
2
2001
116
0.090
 Why?
Lymph Nodes
1
2012
257
0.090
 Why?
beta 2-Microglobulin
2
2007
39
0.090
 Why?
JNK Mitogen-Activated Protein Kinases
2
2007
71
0.080
 Why?
Early Growth Response Protein 1
1
2009
34
0.080
 Why?
Myocardium
1
2012
445
0.080
 Why?
Dexamethasone
3
2007
432
0.080
 Why?
Sphingosine
1
2009
28
0.080
 Why?
Organoids
1
2009
36
0.080
 Why?
Lysophospholipids
1
2009
44
0.080
 Why?
Drug Screening Assays, Antitumor
1
2009
131
0.080
 Why?
Prospective Studies
5
2016
2378
0.080
 Why?
Caspases
1
2009
103
0.080
 Why?
p38 Mitogen-Activated Protein Kinases
1
2009
93
0.080
 Why?
Leukocytes, Mononuclear
1
2009
118
0.080
 Why?
Enzyme Activation
1
2009
268
0.080
 Why?
Glucuronidase
2
2007
48
0.080
 Why?
Lentivirus
1
2008
17
0.080
 Why?
Wnt3 Protein
1
2008
7
0.080
 Why?
Ellipticines
1
2008
2
0.080
 Why?
Wnt3A Protein
1
2008
10
0.080
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
67
0.070
 Why?
Bone Density Conservation Agents
1
2009
74
0.070
 Why?
B-Cell Activating Factor
1
2007
3
0.070
 Why?
Precancerous Conditions
1
2008
82
0.070
 Why?
Cytological Techniques
1
2007
14
0.070
 Why?
Diploidy
1
2007
26
0.070
 Why?
Genetic Vectors
1
2008
128
0.070
 Why?
RNA Interference
1
2008
178
0.070
 Why?
Phosphorylation
1
2009
525
0.070
 Why?
Karyotyping
1
2007
65
0.070
 Why?
Heparan Sulfate Proteoglycans
1
2007
11
0.070
 Why?
Hematopoietic Stem Cell Transplantation
1
2012
577
0.070
 Why?
Kidney
1
2012
696
0.070
 Why?
Reactive Oxygen Species
1
2009
409
0.070
 Why?
Receptor Activator of Nuclear Factor-kappa B
2
2004
33
0.070
 Why?
Mice, Inbred C57BL
1
2012
1808
0.070
 Why?
Phenotype
2
2009
739
0.070
 Why?
Models, Animal
1
2007
227
0.070
 Why?
Immunosuppressive Agents
1
2008
225
0.070
 Why?
Treatment Outcome
6
2017
5285
0.070
 Why?
Risk Assessment
3
2018
1269
0.060
 Why?
Gelatinases
1
2006
32
0.060
 Why?
Endopeptidases
1
2006
65
0.060
 Why?
Survival Analysis
2
2018
661
0.060
 Why?
Adult
6
2018
13584
0.060
 Why?
Antigens, CD34
1
2005
75
0.060
 Why?
RANK Ligand
2
2004
187
0.060
 Why?
Fetal Tissue Transplantation
1
2005
10
0.060
 Why?
Hematologic Neoplasms
1
2006
99
0.060
 Why?
Metaphase
2
2016
45
0.060
 Why?
Molecular Sequence Data
1
2006
778
0.060
 Why?
Endothelium, Vascular
1
2006
251
0.060
 Why?
Annexin A5
1
2004
14
0.060
 Why?
Culture Media, Conditioned
1
2004
47
0.060
 Why?
Phagocytosis
1
2004
44
0.060
 Why?
Survival Rate
2
2018
909
0.060
 Why?
Clinical Trials as Topic
3
2016
486
0.060
 Why?
Membrane Proteins
1
2006
332
0.050
 Why?
Pregnancy
1
2011
2451
0.050
 Why?
Polymerase Chain Reaction
1
2005
449
0.050
 Why?
Endothelial Growth Factors
1
2002
9
0.050
 Why?
Vascular Endothelial Growth Factors
1
2002
13
0.050
 Why?
Lymphokines
1
2002
19
0.050
 Why?
Biotransformation
1
2002
84
0.050
 Why?
Oxidative Stress
1
2007
772
0.050
 Why?
Blotting, Western
2
2015
578
0.050
 Why?
Vascular Endothelial Growth Factor A
1
2002
182
0.050
 Why?
Oncogenes
1
2021
57
0.050
 Why?
Combined Modality Therapy
2
2016
641
0.050
 Why?
Imidazoles
1
2002
127
0.050
 Why?
Chromatin
1
2021
137
0.050
 Why?
Polycomb Repressive Complex 2
1
2021
46
0.050
 Why?
Cell Polarity
1
2000
17
0.040
 Why?
Liver Transplantation
1
2002
154
0.040
 Why?
Cell Transplantation
1
1999
3
0.040
 Why?
Mice, Inbred ICR
1
1999
23
0.040
 Why?
Histones
1
2021
297
0.040
 Why?
Cell Membrane
1
2000
246
0.040
 Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
 Why?
Genes, Immunoglobulin Heavy Chain
1
2019
12
0.040
 Why?
Dose-Response Relationship, Drug
2
2016
1372
0.040
 Why?
Radiation Chimera
1
1998
4
0.040
 Why?
Osteoprotegerin
3
2006
54
0.040
 Why?
Aged, 80 and over
2
2017
3227
0.040
 Why?
Clone Cells
1
1998
70
0.040
 Why?
Multivariate Analysis
2
2012
583
0.040
 Why?
Radiography
2
2012
486
0.040
 Why?
In Situ Hybridization, Fluorescence
1
2019
231
0.040
 Why?
DNA-Binding Proteins
1
2021
418
0.040
 Why?
Tomography, X-Ray Computed
2
2017
1169
0.040
 Why?
False Positive Reactions
1
2017
59
0.030
 Why?
Liver
1
2002
1132
0.030
 Why?
Indolizines
1
2015
5
0.030
 Why?
Cyclic N-Oxides
1
2015
13
0.030
 Why?
Imaging, Three-Dimensional
1
2017
151
0.030
 Why?
Transcriptome
1
2018
314
0.030
 Why?
Drug Synergism
1
2015
151
0.030
 Why?
S Phase
1
2015
18
0.030
 Why?
Genes, BRCA1
1
2015
19
0.030
 Why?
Follow-Up Studies
2
2013
2242
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2015
181
0.030
 Why?
Predictive Value of Tests
2
2007
930
0.030
 Why?
Enzyme-Linked Immunosorbent Assay
1
2015
234
0.030
 Why?
Transcription, Genetic
1
2015
361
0.030
 Why?
DNA Damage
1
2015
301
0.030
 Why?
Transfection
2
2004
356
0.030
 Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.020
 Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.020
 Why?
Acute Disease
1
2013
373
0.020
 Why?
Interleukin-2
1
2012
71
0.020
 Why?
Mice, Inbred NOD
1
2012
91
0.020
 Why?
Immunoenzyme Techniques
1
2012
137
0.020
 Why?
Creatinine
1
2012
145
0.020
 Why?
Glomerular Filtration Rate
1
2012
119
0.020
 Why?
Lymphocyte Activation
1
2012
164
0.020
 Why?
Receptors, Tumor Necrosis Factor
2
2001
38
0.020
 Why?
C-Reactive Protein
1
2012
144
0.020
 Why?
Receptors, Cytoplasmic and Nuclear
2
2001
68
0.020
 Why?
Proportional Hazards Models
1
2012
415
0.020
 Why?
Radiation-Sensitizing Agents
1
2010
51
0.020
 Why?
Inhibitor of Apoptosis Proteins
1
2009
21
0.020
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2009
12
0.020
 Why?
Incidence
1
2013
1032
0.020
 Why?
Protein Transport
1
2010
181
0.020
 Why?
Microtubule-Associated Proteins
1
2009
66
0.020
 Why?
Peptides
1
2010
221
0.020
 Why?
Down-Regulation
1
2009
340
0.020
 Why?
CDC2-CDC28 Kinases
1
2008
11
0.020
 Why?
Salvage Therapy
1
2008
137
0.020
 Why?
Protein Binding
1
2009
654
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2009
226
0.020
 Why?
Proteins
1
2010
339
0.020
 Why?
Antineoplastic Agents, Hormonal
1
2007
49
0.020
 Why?
Retrospective Studies
2
2012
6264
0.020
 Why?
Cytogenetic Analysis
1
2007
74
0.020
 Why?
Phospholipase C gamma
1
2006
4
0.020
 Why?
Chi-Square Distribution
1
2007
277
0.020
 Why?
Caspase 9
1
2006
14
0.020
 Why?
Cell Cycle
1
2008
226
0.020
 Why?
Mitogen-Activated Protein Kinase 3
1
2006
49
0.020
 Why?
Cyclin D
1
2006
18
0.020
 Why?
Cyclins
1
2006
38
0.020
 Why?
Bone Marrow Transplantation
1
2007
136
0.020
 Why?
RNA, Neoplasm
1
2006
43
0.020
 Why?
src-Family Kinases
1
2006
51
0.020
 Why?
Case-Control Studies
1
2009
1155
0.020
 Why?
Proto-Oncogene Proteins c-akt
1
2006
156
0.020
 Why?
Mice, Inbred BALB C
1
2006
296
0.020
 Why?
Chromosome Mapping
1
2006
153
0.020
 Why?
Phosphatidylinositol 3-Kinases
1
2006
140
0.020
 Why?
Cluster Analysis
1
2006
219
0.020
 Why?
Kaplan-Meier Estimate
1
2007
464
0.020
 Why?
Data Interpretation, Statistical
1
2006
162
0.020
 Why?
Transplantation, Autologous
1
2007
481
0.010
 Why?
Logistic Models
1
2007
899
0.010
 Why?
DNA, Complementary
1
2004
133
0.010
 Why?
Young Adult
1
2013
4107
0.010
 Why?
Recombinant Proteins
1
2004
476
0.010
 Why?
Randomized Controlled Trials as Topic
1
2005
573
0.010
 Why?
Solubility
1
2002
71
0.010
 Why?
Leukemia, Plasma Cell
1
2002
32
0.010
 Why?
Acid Phosphatase
1
2001
12
0.010
 Why?
Protein Structure, Tertiary
1
2002
245
0.010
 Why?
Adolescent
1
2013
6446
0.010
 Why?
Neoplasm Invasiveness
1
2002
269
0.010
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2001
46
0.010
 Why?
Hodgkin Disease
1
2001
47
0.010
 Why?
Isoenzymes
1
2001
168
0.010
 Why?
Reference Values
1
2001
307
0.010
 Why?
Paraproteinemias
1
2001
72
0.010
 Why?
LDL-Receptor Related Protein-Associated Protein
1
2000
1
0.010
 Why?
Hepatocyte Growth Factor
1
2000
10
0.010
 Why?
Intercellular Adhesion Molecule-1
1
2000
62
0.010
 Why?
Epithelial Cells
1
2000
207
0.010
 Why?
Yaccoby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (361) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department